Evolution of Symptoms After Sacrospinofixation With Posterior Isthmic Band
Launched by HOSPICES CIVILS DE LYON · Apr 10, 2019
Trial Information
Current as of July 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • women over 18
- • apical prolapse requiring surgical correction of grade II or greater in the Pelvic Organ Prolapse Quantification (POP-Q) classification
- • patients who wish an intervention because of the discomfort caused by prolapse
- • sacrospinofixation procedure with posterior isthmic band Bilateral Sacrospinous Colposuspension (BSC) Mesh provided
- • person having expressed his non-opposition
- Exclusion Criteria:
- • apical prolapse of stage \< II in the Pelvic Organ Prolapse Quantification (POP-Q) classification, and prolapse without functional discomfort
- • disorders leading to an unacceptable risk of postoperative complications sought during the interrogation of the patient (disorders of blood coagulation, disorders of the immune system, progressive diseases ....)
- • reduced mobility of the lower limbs (not allowing positioning for surgery)
- • pregnancy or any plans for pregnancy during the study period
- • evolutionary or latent infection
- • known hypersensitivity to polypropylene
- • inability to understand the information given
- • person deprived of liberty, under guardianship.
About Hospices Civils De Lyon
Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bron, , France
Patients applied
Trial Officials
Gautier CHENE, Ph.D.
Principal Investigator
Hospices Civils de Lyon, Hôpital Femme Mère Enfant
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials